Literature DB >> 386429

Beneficial actions of prostacyclin in traumatic shock.

A M Lefer, S L Sollott, M J Galvin.   

Abstract

Prostacyclin (PGI2) infused at a rate of 350 ng/kg/min significantly increased survival time in rats subjected to Noble-Collip drug trauma from 2.7 +/- 0.3 to 4.6 +/- 0.2 h (p less than 0.01) compared with traumatized rats given only the vehicle (Tris buffer). Moreover, PGI2 treated rats exhibited significantly lower circulating cathepsin D and myocardial depressant factor (MDF) activities, indicative of lower lysosomal disruption and lower toxic factor formation. PGI2 induced vasodilation in rats as well as these other protective effects.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 386429     DOI: 10.1016/s0090-6980(79)80048-9

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  5 in total

1.  Novel mechanism of action of a prostacyclin enhancing agent in haemorrhagic shock.

Authors:  H Bitterman; D J Lefer; A M Lefer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-06       Impact factor: 3.000

2.  Attenuation of ischemia reperfusion-induced lung edema by prostaglandin I2 analogue OP-2507 in the isolated perfused rat lung.

Authors:  Masahiro Okuda; Kazuhisa Furuhashi; Yasushi Nakai; Homare Amano; Mannosuke Muneyuki
Journal:  J Anesth       Date:  1994-12       Impact factor: 2.078

3.  Pulmonary and haemodynamic effects of extracorporeal circulation in the cat and the beneficial effects of prostacyclin.

Authors:  J Jahr; P O Grände
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

4.  Effects of prostacyclin analogue, OP-2507, on function and metabolism in the ischemic working rat heart.

Authors:  T Oguchi; S Kashimoto; T Nakamura; T Kumazawa
Journal:  J Anesth       Date:  1992-10       Impact factor: 2.078

5.  Protective effects of prostaglandin I2 analogues on CPK release in rat's heart-lung preparation.

Authors:  S Kashimoto; T Nakamura; T Oguchi; M Kume; T Kumazawa
Journal:  J Anesth       Date:  1991-10       Impact factor: 2.078

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.